| Literature DB >> 30878952 |
Christina Awad1, Karin Gilkison2, Erwin Shaw2.
Abstract
Lanthanum carbonate is a phosphate binder that is used to reduce serum phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum forms insoluble lanthanum phosphate complexes that are supposed to pass through the gastrointestinal (GI) tract unabsorbed. Phosphate binders have been reported to deposit in the GI tract and can cause mucosal injury. There are few case reports of GI bleeding associated with phosphate binder deposits. This case report presents a patient with iron deficiency anaemia secondary to biopsy-proven lanthanum deposits in the upper GI tract. There were no overt signs of active GI bleeding. Patient's anaemia improved with discontinuation of the phosphate binder. Lanthanum could be a hidden cause of resistant anaemia among patients with ESRD through asymptomatic GI blood loss. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: Gi bleeding; drugs: gastrointestinal system; gastrointestinal system; oesophagus; ulcer
Mesh:
Substances:
Year: 2019 PMID: 30878952 PMCID: PMC6424195 DOI: 10.1136/bcr-2018-226157
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X